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P R O L A C T I N S E C R E T I O N I N P A T I E N T S W I T H P I T U I T A R Y T U M O R S * 
Κ. v. Werden, C. R. Pickardt1, B. Glöckner1, 
Μ. Gottsmann1, Η. Κ. Rjosk* and P. C. Scriba1 
Problem: To elucidate the dynamics of prolactin (hPR) secretion in patients w i th 
pituitary tumors we set up a double antibody hPR-radioimmunoassay using the V. 
L . S.-reagents (National Pituitary Agency, N I A M D , USA) . 
Methods: 1 μξ of Lewis-hPR was labelled w i t h the chloramine-T-method and 
purified by one column chromatography on Sephadex G-100. Pooled pregnancy 
serum calibrated w i t h the research standard A-71/222 ( M R C , Division of Biolog. 
Stand., H o l l y H i l l , London) served as standard: 1 m l of this standard serum con­
tained 4000 μϋ of hPR-71/222, which was equivalent to 200 ng hPR-V.L.S. A l l 
data were expressed in μϋ hPR-72/222. There was only 0.1 °/o crossreactivity w i th 
h G H and none w i t h hPL, L H , T S H . The sensitivity of the assay (Bo ± 3 SD) was 
12 μϋ/ml, the between assay coefficient of variation was 9.1°/o. 
Results: The basal hPR-levels in normal males ranged from 170 to 500 μϋ/ml 
(Ν = 21), in females up to 650 μϋ/ml (Ν = 20). 5 5 % of patients w i t h active 
acromegaly (N = 22) had elevated basal hPR-levels ranging from 720 to 
5400 μϋ/ml, whereas only 3 of 15 patients w i t h inactive acromegaly had still ele­
vated hPR-levels. N o correlation existed between tumor size, hGH-secretion, and 
the hPR-level. The response to T R H was blunted in most patients tested. — The 
basal hPR-levels of 8 patients w i t h amenorrhea, galactorrhea and pi tui tary tumor 
(Forbes-Albright syndrome) ranged from 2300 to 85000 μϋ/ml, the patients wi th 
the larger tumors having the higher hPR-levels. T R H injection caused only little 
further increase of the hPR-level. The hPR-levels could be effectively lowered by 
the removal of the tumor or by administration of CB 154, w i t h concomitant disap­
pearance of galactorrhea and amenorrhea. Three patients w i t h galactorrhea wi th ­
out pi tui tary tumors had normal hPR-levels w i t h a normal rise after T R H . — A 
dissociation of the T S H and hPR-response to T R H was seen in several of the 
patients w i t h disorders of thyroid function. hPR-levels below the normal range 
w i t h nonresponsiveness to T R H were only found in patients w i t h complete ante­
rior pituitary failure. 
Conclusions: These results demonstrate that hyperprolactinemia is not only 
found in patients w i t h hPR-producing tumors, though in these patients the hPR-
levels may be extremely elevated, correlating w i t h the tumor's size. Whether 
hyperprolactinemia in acromegaly is due to hypothalamic dysfunction, i . e. lack of 
PIF, or is rather a result of autonomous hypersecretion of hPR is sti l l unclear. The 
blunted response to T R H in most cases, however, and the fact that small tumors 
can be accompanied by elevated hPR-levels, would favour an autonomous hPR-
hypersecretion. 
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